Blue Water Vaccines in pact to study Alzheimer’s vaccine

Jul. 20, 2022 3:31 PM ETBlue Water Vaccines, Inc. (BWV)By: Dulan Lokuwithana, SA News Editor1 Comment

Alzheimers Concept Horizontal

travellinglight/iStock via Getty Images

  • Newly IPO’d biotech Blue Water Vaccines (NASDAQ:BWV) announced a sponsored research agreement with Cincinnati Children’s Hospital Medical Center on Wednesday to study vaccine candidates for conditions such as Alzheimer’s. The news sent company shares

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.